🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Modification of the EGF signalling pathway and / or HER 2, by Lapatinib in ...
Status
Terminated
Location
CHU Bordeaux - Hôpital Saint André - Department of Medical Oncology
Start Date
2011-01
Trial ID
NCT01245660
Treatments Being Tested
This is a safety and tolerability study of GW572016 given with docetaxel (T...
Status
Completed
Location
GSK Investigational Site
Start Date
2003-04-28
Trial ID
NCT00148902
RATIONALE: Drugs used in chemotherapy, such as docetaxel and carboplatin, w...
Status
Completed
Location
Mayo Clinic Scottsdale
Start Date
2009-02
Trial ID
NCT00820872
Treatments Being Tested
Phase II randomized multicenter trial to compare Epirubicin and Cyclophosph...
Status
Completed
Location
Hospital Germans Trias i Pujol
Start Date
2009-02
Trial ID
NCT00841828
Treatments Being Tested
An open-label, randomized three-arm Phase II trial to explore the efficacy ...
Status
Completed
Location
1200.44.01001 Boehringer Ingelheim Investigational Site
Start Date
2009-01
Trial ID
NCT00826267
Treatments Being Tested
Lapatinib ditosylate may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center
Start Date
2005-10
Trial ID
NCT00107536
Treatments Being Tested
This study will estimate the effect of lapatinib on cardiac repolarization ...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-12
Trial ID
NCT01328054
Treatments Being Tested
The MOST Plus study is a two-period phase II clinical trial, conducted in p...
Status
Recruiting
Location
Institut Bergonié
Start Date
2014-03
Trial ID
NCT02029001
RATIONALE: Lapatinib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
Start Date
2005-10
Trial ID
NCT00246753
Treatments Being Tested
RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone th...
Status
Unknown
Location
Federico II University Medical School
Start Date
2008-05
Trial ID
NCT00688194
Treatments Being Tested